Intracardiac allogeneic mesenchymal stem cell transplantation elicits neo-angiogenesis in a fully immunocompetent ischaemic swine model

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 6, 2010, Pages 781-787

  Poncelet, Alain J ^a,b   Hiel, Anne Lise ^a   Vercruysse, Jonathan ^a   Hermans, Dominique ^a   Zech, Francis ^b   Gianello, Pierre ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Allogeneic; Angiogenesis; Mesenchymal stem cells; Miniature swine

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; CD3 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY CD68; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CARDIAC GRAFT REJECTION; CARDITIS; CD3+ T LYMPHOCYTE; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTRACARDIAC ALLOGENEIC MESENCHYMAL STEM CELL TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MINIPIG; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; CAPILLARIES; CELLS, CULTURED; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; SWINE, MINIATURE; TACROLIMUS;

EID: 78649321704     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.03.035     Document Type: Article

References (25)

1. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
2. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., Hanley A., Scadova H., Qin G., Cha D.H., Johnson K.L., Aikawa R., Asahara T., Losordo D.W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005, 115:326-338.
3. Cho H.J., Lee N., Lee J.Y., Choi Y.J., Ii M., Wecker A., Jeong J.O., Curry C., Qin G., Yoon Y.S. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007, 204:3257-3269.
4. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., Nurzynska D., Kasahara H., Zias E., Bonafe M., Nadal-Ginard B., Torella D., Nascimbene A., Quaini F., Urbanek K., Leri A., Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005, 96:127-137.
5. Uemura R., Xu M., Ahmad N., Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006, 98:1414-1421.
6. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., Coulter S.C., Lin J., Ober J., Vaughn W.K., Branco R.V., Oliveira E.M., He R., Geng Y.J., Willerson J.T., Perin E.C. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111:150-156.
7. Zeng L., Hu Q., Wang X., Mansoor A., Lee J., Feygin J., Zhang G., Suntharalingam P., Boozer S., Mhashilkar A., Panetta C.J., Swingen C., Deans R., From A.H., Bache R.J., Verfaillie C.M., Zhang J. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 2007, 115:1866-1875.
8. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S., Number migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
9. Badillo A.T., Beggs K.J., Javazon E.H., Tebbets J.C., Flake A.W. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant 2007, 13:412-422.
10. Amsalem Y., Mardor Y., Feinberg M.S., Landa N., Miller L., Daniels D., Ocherashvilli A., Holbova R., Yosef O., Barbash I.M., Leor J. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007, 116:I38-I45.
11. Cho P.S., Messina D.J., Hirsh E.L., Chi N., Goldman S.N., Lo D.P., Harris I.R., Popma S.H., Sachs D.H., Huang C.A. Immunogenicity of umbilical cord tissue derived cells. Blood 2008, 111:430-438.
12. Poncelet A.J., Vercruysse J., Saliez A., Gianello P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007, 83:783-790.
13. Oike F., Talpe S., Otsuka M., Dehoux J.P., Lerut J., Otte J.B., Gianello P. A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. Transplantation 2000, 69:2304-2314.
14. Poncelet A.J., Nizet Y., Vercruysse J., Hiel A.L., Saliez A., Gianello P. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus. Transplantation 2008, 86:1586-1595.
15. Dufrane D., Goebbels R.M., Fdilat I., Guiot Y., Gianello P. Impact of porcine islet size on cellular structure and engraftment after transplantation: adult versus young pigs. Pancreas 2005, 30:138-147.
16. McCullagh P. Quasi-likelihood functions. Ann Stat 1983, 11:59-67.
17. Larzelere R.E., Mulaik S.A. Single-sample tests for many correlations. Psychol Bull 1977, 84:557-569.
18. Nagaya N., Fujii T., Iwase T., Ohgushi H., Itoh T., Uematsu M., Yamagishi M., Mori H., Kangawa K., Kitamura S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004, 287:H2670-H2676.
19. Ma N., Stamm C., Kaminski A., Li W., Kleine H.D., Muller-Hilke B., Zhang L., Ladilov Y., Egger D., Steinhoff G. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 2005, 66:45-54.
20. Hashemi S.M., Ghods S., Kolodgie F.D., Parcham-Azad K., Keane M., Hamamdzic D., Young R., Rippy M.K., Virmani R., Litt H., Wilensky R.L. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008, 29:251-259.
21. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., Van de W.F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
22. Imanishi Y., Saito A., Komoda H., Kitagawa-Sakakida S., Miyagawa S., Kondoh H., Ichikawa H., Sawa Y. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 2008, 44:662-671.
23. Coyne T.M., Marcus A.J., Reynolds K., Black I.B., Woodbury D. Disparate host response and donor survival after the transplantation of mesenchymal or neuroectodermal cells to the intact rodent brain. Transplantation 2007, 84:1507-1516.
24. Eliopoulos N., Stagg J., Lejeune L., Pommey S., Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC cla. Blood 2005, 106:4057-4065.
25. Freyman T., Polin G., Osman H., Crary J., Lu M., Cheng L., Palasis M., Wilensky R.L. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006, 27:1114-1122.